(Q39589931)

13 September 2017

title

Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer (English)

1 reference

13 September 2017

1 reference

1 reference

Qiushan He

1

1 reference

13 September 2017

Jinlong Li

2

1 reference

13 September 2017

Weihua Yin

3

1 reference

13 September 2017

Zhichun Song

4

1 reference

13 September 2017

Zhen Zhang

5

1 reference

13 September 2017

Tienan Yi

6

1 reference

13 September 2017

Jia Tang

7

1 reference

13 September 2017

Demin Wu

8

1 reference

13 September 2017

Yue Lu

9

1 reference

13 September 2017

Zhen Wang

10

1 reference

13 September 2017

Dan Liu

11

1 reference

13 September 2017

Xiaoren Zhang

12

1 reference

13 September 2017

Zhiming Hu

13

1 reference

13 September 2017

Jimin Gao

14

1 reference

13 September 2017

publication date

18 February 2011

1 reference

Cancer Immunology, Immunotherapy

13 September 2017

published in

1 reference

13 September 2017

volume

60

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

715-730

1 reference

Global cancer statistics, 2002

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Current indications for chemotherapy in prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Paclitaxel, estramustine and carboplatin combination chemotherapy after initial docetaxel-based chemotherapy in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Prevention of de novo prostate cancer by immunization with tumor-derived vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

GM-CSF gene-transduced tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Current status of experimental therapeutics for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

GM-CSF-surface-modified B16.F10 melanoma cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Docetaxel-based combination therapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

The immunological effects of taxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Chemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

Current status of immunological therapies for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0988-4

10.1007/S00262-011-0988-4

21 January 2018

Identifiers

DOI

1 reference

release_a42p5a4l7rhrphut7n6groakxq

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a42p5a4l7rhrphut7n6groakxq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference